Oklahoma 2023 Regular Session

Oklahoma House Bill HB2424 Latest Draft

Bill / Enrolled Version Filed 04/20/2023

                            An Act 
ENROLLED HOUSE 
BILL NO. 2424 	By: May of the House 
 
   and 
 
  Stephens of the Senate 
 
 
 
 
 
 
An Act relating to opioid antagonists; amending 63 
O.S. 2021, Section 1 -2506.2, which relates to 
prescription of opioid antagonists to famil y members; 
replacing naloxone with opioid antagonist; amending 
63 O.S. 2021, Section 2 -312.2, which relates to the 
sale or dispensation of naloxone; removing naloxone 
and replacing it with opioid antagonist; and 
providing an effective date . 
 
 
 
 
SUBJECT: Opioid antagonists 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
 
SECTION 1.     AMENDATORY     63 O.S. 2021, Section 1 -2506.2, is 
amended to read as follows: 
 
Section 1-2506.2 A.  Upon request, a provider may prescribe an 
opiate opioid antagonist to an individual for use by that individual 
when encountering a family member exhibiting signs of an opiate 
opioid overdose. 
 
B.  When an opiate opioid antagonist is prescribed in accordance 
with subsection A of this section, the provider shall provide: 
 
1.  Information on how to spot symptoms of an overdose; 
 
2.  Instruction in basic resuscitation techniques; 
 
3.  Instruction on proper naloxone opioid antagonist 
administration; and  ENR. H. B. NO. 2424 	Page 2 
 
4.  The importance of calling 911 nine-one-one (911) for help. 
 
C.  Any family member administering a n opiate opioid antagonist 
in a manner consistent with addressing opiate opioid overdose shall 
be covered under the Good Samaritan Act. 
 
D.  Any provider prescribing o r administering an opiate opioid 
antagonist in a manner consistent with addressing opiate opioid 
overdose shall be covered under the Good Samaritan Act. 
 
SECTION 2.     AMENDATORY     63 O.S. 2021, Section 2 -312.2, is 
amended to read as follows: 
 
Section 2-312.2 Naloxone, also known as Na rcan, or any of its 
generic equivalents Any opioid antagonist that is approved by the 
United States Food and Drug Admini stration may be dispensed or sold 
by a pharmacy without a prescription; provided, however, it shall be 
dispensed or sold only by, or und er the supervision of, a licensed 
pharmacist.  Naloxone An opioid antagonist may be prescribed and 
dispensed by a licens ed pharmacist; provided, however, it shall be 
dispensed only by, or under the supervision of, a licensed 
pharmacist.  No dispensing prot ocol shall be required. 
 
SECTION 3.  This act shall become effective November 1, 2023. 
 
 
  ENR. H. B. NO. 2424 	Page 3 
Passed the House of Representati ves the 13th day of March, 2023. 
 
 
 
  
 	Presiding Officer of the House 
 	of Representatives 
 
 
Passed the Senate the 19th day of April, 2023. 
 
 
 
  
 	Presiding Officer of the Senate 
 
 
 
OFFICE OF THE GOVERNOR 
Received by the Office of the Governor this ____________________ 
day of ___________________, 20_______, at _______ o'clock _______ M. 
By: _________________________________ 
Approved by the Governor of the State of Oklahoma this _____ ____ 
day of ___________________, 20_______, at _______ o'clock _______ M. 
 
 
 	_________________________________ 
 	Governor of the State of Oklahoma 
 
OFFICE OF THE SECRETARY OF STATE 
Received by the Office of the Secretary of State this __________ 
day of ___________________, 20_______, at _______ o'clock _______ M. 
By: _________________________________